Investigation of the Impact of Noninvasive Prenatal Testing for Fetal Aneuploidy on Utilization of Prenatal Diagnostic Procedures and Pregnant Women's Views
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Verinata Health, Inc.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Age 18 years or older at enrollment
Clinically confirmed singleton pregnancy
Gestational age between 10 weeks, 0 days and 20 weeks, 0 days
Referred for prenatal genetic counseling due to increased risk for fetal aneuploidy (advanced maternal age (AMA ≥ 35 years at delivery, high-risk prenatal screen result, abnormal fetal ultrasound finding consistent with fetal aneuploidy, and/or history of prior affected pregnancy for fetal aneuploidy)
Pregnancy records accessible and available for data collection (e.g., results from screening, ultrasound examinations, invasive prenatal procedures if performed, and infant hospital discharge exam)
Able to provide consent for participation using language-appropriate forms
You may not be if
Invasive prenatal procedure (amniocentesis or CVS) already performed
History of demised or vanished co-twin (spontaneous or following in vitro fertilization)
Clareo Health | Investigation of the Impact of Noninvasive Prenatal Testing for Fetal Aneuploidy on Utilization of Prenatal Diagnostic Procedures and Pregnant Women's Views
